#United States #Skincare #Denver #IPL #Dr. Ci:Labo

Breakthrough in Post-IPL Skincare by Dr. Ci:Labo

Dr. Ci:Labo, a skincare brand that aims to maximize the beauty potential of individuals through innovative dermatological science, showcased groundbreaking research findings at the 2026 AAD Annual Meeting held in Denver, Colorado from March 27th to 31st. This study focused on the effectiveness and tolerability of a skincare regimen consisting of lotion, gel, and a sunscreen serum following Intense Pulsed Light (IPL) treatment.

Background of the Presentation

As beauty treatments like IPL become increasingly common, it is crucial to acknowledge the challenges faced by skin post-procedure, such as diminished barrier function, inflammation, and dryness. Proper aftercare is essential for maximizing treatment effects. Dr. Ci:Labo emphasized the need for skincare that not only supports skin recovery post-treatment but also enhances aesthetic outcomes. This study scientifically validated the benefits of supplementary skincare regimes in this context.

Overview of the Study

The clinical study involved 46 participants with both normal and sensitive skin, utilizing a ‘split-face design’ where different skincare regimens were applied to each side of the face.

Treatment Group:

Participants used:

• - Lotion + Gel (twice daily)
• - Sunscreen Serum (once daily)

Both the lotion and gel included AHP (Acetyl Hydroxyproline), while the sunscreen serum featured 377 (Phenethyl Resorcinol) and was enhanced with the proprietary shielding technology, Smart Layers™.

Control Group:

Participants used a base agent combined only with the sunscreen serum.

The study assessed various indicators over a 14-day period post-treatment:

• - Skin hydration levels
• - Transepidermal water loss (TEWL)
• - Skin tone (ITA values)
• - Redness (erythema)

Key Findings

Dr. Ci:Labo identified AHP for its ability to gently condition sensitive skin and support barrier function and hydration, while also recognizing the benefits of 377 (Phenethyl Resorcinol) for inhibiting melanin production and enhancing skin brightness. The combination of AHP-based lotion and gel along with the 377-infused sunscreen serum led to multifaceted improvements for patients post-IPL treatment, resulting in enhanced skin hydration, improved skin tone, reduced redness and inflammation, and restored barrier function. Furthermore, when compared to the use of the sunscreen serum alone, there were significant improvements in erythema and skin color, suggesting a minimalization of IPL side effects and an ability to apply products safely on fragile post-treatment skin without causing damage, thus indicating a flexible approach to care based on lifestyle choices.

1. Enhanced Skin Hydration and Barrier Function:
The treatment regimen resulted in a significant increase in skin hydration, while TEWL measurements indicated a marked improvement in barrier function. This confirms enhanced skin moisture and recovery of barrier integrity.

2. Reduction of Redness:
Both sensitive and normal skin participants demonstrated significant reductions in erythema, a common concern post-IPL treatment in the regimen group.

3. Improvement in Skin Tone:
Significant improvements were observed in the brightness metric (ITA values), contributing to reduced dullness and enhanced translucence.

4. Exceptional Safety and Tolerance:
All participants reported excellent tolerance to the products, with no adverse effects observed. A remarkable 100% stated that the skincare regimen was gentle and suitable for post-treatment use.

Special Ingredients and Technologies

AHP (Acetyl Hydroxyproline)

• - Promotes ceramide production
• - Enhances barrier function and hydration
• - Supports recovery of post-treatment skin

377 (Phenethyl Resorcinol)

• - Inhibits melanin production
• - Enhances skin brightening effects

Smart Layers™ Technology

• - Combines an exterior UV protection layer with an internal skincare layer structure
• - Formulated to minimize skin burden while providing UV defense

Leveraging these research findings, Dr. Ci:Labo is set to further advance the fusion of beauty treatment and skincare, with a commitment to providing new value in post-procedure care.